Detection of MUC1 protein on tumor cells and their derived exosomes for breast cancer surveillance with an electrochemiluminescence aptasensor

Rui Li,Yu An,Tongyu Jin,Fan Zhang,Pingang He

DOI: https://doi.org/10.1016/j.jelechem.2021.115011

IF: 4.598

2021-02-01

Journal of Electroanalytical Chemistry

Abstract:<p>As a kind of malignant tumor, breast cancer needs more simple and sensitive diagnosis methods. Exosomes, a novel cancer marker, have the potential to be used in cancer biopsy alternative surveillance. Thus, the determination of the correlation between cancer cells and their exosome composition is of significance. Herein, an electrochemiluminescence (ECL) aptasensor has been designed to detect the MUC1 protein expression on breast cancer cells and their derived exosomes. CD63 aptamer was immobilized on the electrode surface to capture the cells and exosomes, and Ru(bpy)₃²⁺@SiO₂ nanoparticles (₂ NPs) modified with MUC1 aptamer could recognize specifically MUC1 protein on cells and exosomes. The amplified ECL signal from ₂ NPs exhibited linear responses in the range of 7.53 to 753 μg/mL with a limit of detection (LOD) of 0.83 μg/mL for MCF-7 cells, as well as linear range of 3.22 × 10⁻⁴ to 156 μg/mL with a LOD of 2.73 × 10⁻⁴ μg/mL for their exosomes. The expression of MUC1 protein on the surface of MDA-MB-231 and SK-BR-3 cells and their exosomes, were further analyzed, indicating the consistency of MUC1 expression of breast cancer cells and their exosomes. Furthermore, this aptasensor was applied to the determination of MUC1 protein on exosomes in serum samples of patient and normal control, demonstrating its potential for clinical cancer surveillance.</p>

chemistry, analytical,electrochemistry

What problem does this paper attempt to address?

The problem this paper attempts to address is the development of a simple and sensitive method for diagnosing breast cancer. Specifically, the researchers designed an electrochemiluminescence (ECL) aptamer sensor to detect the expression of MUC1 protein on breast cancer cells and their derived exosomes. MUC1 is a high molecular weight membrane glycoprotein that is highly or abnormally expressed on breast cancer cells and their exosomes, playing an important role in tumor invasion, metastasis, and susceptibility. Through this method, the researchers aim to achieve high sensitivity detection of MUC1 protein in breast cancer cells and their exosomes, and further explore its potential application in clinical cancer monitoring.

### Background and Objectives
- **Background**: Breast cancer is one of the most common malignant tumors with high incidence and mortality rates. Currently, commonly used pathological diagnostic methods require clinical information as well as qualified, sufficient, and complete biopsy or tissue specimens, which may cause significant physical and mental harm to patients.
- **Objective**: To develop a simple and sensitive method to detect the expression of MUC1 protein on breast cancer cells and their derived exosomes, in order to improve the early diagnosis and monitoring capabilities of breast cancer.

### Methods
- **Aptamer Sensor Design**: The researchers used CD63 aptamer fixed on the electrode surface to capture cells and exosomes. Meanwhile, Ru(bpy)₃²⁺@SiO₂ nanoparticle-modified MUC1 aptamer can specifically recognize MUC1 protein on the surface of cells and exosomes.
- **Detection Performance**: By amplifying the electrochemiluminescence signal, high sensitivity detection of MUC1 protein expression was achieved. The detection range is 7.53 to 753 μg/mL, with a detection limit of 0.83 μg/mL (for MCF-7 cells), and the detection range for exosomes is 3.22 × 10⁻⁴ to 156 μg/mL, with a detection limit of 2.73 × 10⁻⁴ μg/mL.

### Results
- **Cell and Exosome Detection**: The researchers analyzed the expression of MUC1 protein on the surface of MCF-7, MDA-MB-231, and SK-BR-3 cells and their exosomes. The results showed that the expression trend of MUC1 protein was consistent across different cell lines and their exosomes.
- **Clinical Sample Detection**: The aptamer sensor was applied to serum samples from breast cancer patients and healthy controls. The results indicated that the expression level of MUC1 protein in exosomes from breast cancer patients was higher than that in healthy individuals, demonstrating the potential application value of this method in clinical cancer monitoring.

### Conclusion
The researchers successfully constructed an electrochemiluminescence aptamer sensor that can detect the expression of MUC1 protein on breast cancer cells and their exosomes with high sensitivity. This method has the advantages of being simple to operate, low cost, and high stability, and is expected to play an important role in future clinical cancer monitoring.